Vaxcyte Inc expected to post a loss of $1.07 a share - Earnings Preview

Vaxcyte

24/02/2024 24:01

* Vaxcyte Inc  PCVX.OQ   PCVX.O  is expected to show no
change in
quarterly revenue when it reports  results on February 27 for
the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Vaxcyte Inc is for a
loss of
$1.07 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$76.00​, below​ its last closing price of $76.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.84       -0.84      -0.91     Missed  -8.7
 Jun. 30 2023  -0.75       -0.74      -0.70     Beat    6
 Mar. 31 2023  -0.84       -0.83      -0.70     Beat    15.2​
 Dec. 31 2022  -0.98       -0.93      -1.02     Missed  -9.7
 ​​Sep.        -0.84       -0.84      -0.93     Missed  -11.2
 30 2022                                                
 Jun. 30 2022  -0.69       -0.69      -0.80     Missed  -15.9​
 Mar. 31 2022  -0.64       -0.63      -0.68     Missed  -8.5
 Dec. 31 2021  -0.52       -0.56      -0.55     Beat    1.8
 This summary was machine generated February 24 at 00:00 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)